Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q1 2019 Earnings

7FebConfirmed

Q2 2018

Q3 2018

Q4 2018

Q1 2019

-9.06

-7.7

-6.34

-4.97

Details

Expected EPS

-8.544039999999999

Actual EPS

-7.763932

Surprise EPS

0.78

Surprise Percent

+9.13%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -7.763932 per share for Q1 2019.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.